PCN99 Cost-Effectiveness Evaluation of Sunitinib as First-Line Targeted Therapy for Metastatic Renal Cell Carcinoma in Kazakhstan

No Thumbnail Available

Date

2014-05-01

Authors

Kostyuk, A.
A., Kostyuk
Nurgozhin, T.
Mazhitov, T.
Almadiyeva, A.

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Description

Keywords

Citation

A. Kostyuk, T. Nurgozhin, T. Mazhitov, A. Almadiyeva, PCN99 - Cost-Effectiveness Evaluation of Sunitinib as First-Line Targeted Therapy for Metastatic Renal Cell Carcinoma in Kazakhstan, In Value in Health, Volume 17, Issue 3, 2014, Page A85